Global Ophthalmic Combination Product Market Set to Total USD 25.9 Billion by 2034, Spurred by Rising Prevalence of Eye Disorders | Future Market Insights, Inc. [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Alimera Sciences, Inc. (ALIM)
Last alimera sciences, inc. earnings: 4/29 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.alimerasciences.com/investor-relations
Company Research
Source: Yahoo! Finance
The global ophthalmic combination product market is witnessing rapid growth and innovation, driven by advancements in medical technology and increasing prevalence of eye disorders worldwide Top of FormBottom of Form NEWARK, DE / ACCESSWIRE / July 14, 2024 / The global ophthalmic combination product market value is anticipated to total USD 12.9 billion in 2024 and USD 25.9 billion by 2034. Global ophthalmic combination product demand will likely surge at a CAGR of during the forecast period. The devices segment dominates the industry, holding a share value of in 2024. This is due to high-end technological development in drug delivery devices and the simplification of drug delivery by these devices. Request A Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-19638 The future of the ophthalmic combination products industry looks bright. This is due to factors like increasing incidence of eye diseases like glaucoma and dry eye syndrome, surging demand for e
Show less
Read more
Impact Snapshot
Event Time:
ALIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALIM alerts
High impacting Alimera Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
ALIM
News
- Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALIM, INFN on Behalf of ShareholdersPR Newswire
- ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIMBusiness Wire
ALIM
Earnings
- 8/6/24 - Miss
ALIM
Sec Filings
- 8/8/24 - Form DEFM14A
- 8/7/24 - Form 10-Q
- 8/6/24 - Form 425
- ALIM's page on the SEC website